Fact-checked by Grok 2 weeks ago

3-Hydroxypropionic acid

3-Hydroxypropionic acid, also known as 3-hydroxypropanoic acid or hydracrylic acid, is a three-carbon β-hydroxy with the molecular formula C₃H₆O₃ and a molecular weight of 90.08 g/mol. It appears as a colorless, that is highly soluble in , exhibiting a of 1.066 g/mL at 25°C and a refractive index of n/D 1.449. Chemically, it features both a hydroxyl group at the beta position and a carboxyl group, making it a non-chiral compound with a pKa of approximately 4.5 for the moiety. As a versatile platform chemical, 3-hydroxypropionic acid serves as a key building block for the synthesis of high-value industrial products, including (a precursor to polymers and adhesives), (used in polyesters and antifreeze), acrylonitrile, and biodegradable polymers such as poly(3-hydroxypropionate) (P3HP). Its global market potential is significant, with projections as of 2023 estimating potential demand exceeding 3.6 million tons per year and a potential value over USD 10 billion annually (for derivatives), driven by applications in sustainable materials, cleaning agents, fibers, and pharmaceuticals; updated direct market projections reach USD 1.3 billion by 2030. Biologically, 3-hydroxypropionic acid functions as a human metabolite and microbial intermediate, primarily arising from the of branched-chain and gut-derived via propionyl-CoA pathways. Elevated concentrations can act as a metabotoxin, contributing to ( < 7.35) in conditions like or biotinidase deficiency, leading to symptoms such as , seizures, and neurological issues. It is also produced by microorganisms like and . Industrial production of 3-hydroxypropionic acid predominantly relies on microbial fermentation using metabolically engineered strains of bacteria (e.g., E. coli, Klebsiella pneumoniae) or yeast (Saccharomyces cerevisiae) from renewable feedstocks such as glycerol, glucose, or lignocellulosic biomass. Key biosynthetic routes include the glycerol pathway (via 3-hydroxypropionaldehyde), malonyl-CoA pathway, and β-alanine pathway, with optimized fed-batch processes achieving titers up to 154 g/L. Challenges include toxicity to host cells, cofactor dependencies (e.g., coenzyme B12), and by-product formation, which ongoing genetic engineering aims to address for scalable, sustainable manufacturing.

Properties

Physical properties

3-Hydroxypropionic acid, also known as 3-hydroxypropanoic acid, has the molecular formula C₃H₆O₃ and the structural formula HO-CH₂-CH₂-COOH, consisting of a three-carbon chain with a beta-hydroxy functionality. Its is 90.08 g/mol. At , 3-hydroxypropionic acid appears as a viscous, colorless to almost colorless syrupy . It has a low below 25 °C, remaining in the state under standard ambient conditions. The compound decomposes before reaching its boiling point under normal pressure, with a rough estimated boiling temperature of 212 °C; is typically conducted under reduced pressure in the range of 200-250 °C to avoid decomposition. It is miscible with and soluble in , , and . As a polar , it is insoluble in non-polar solvents such as . The group imparts weak acidity, with a value of 4.51 at 25 °C.

Chemical properties

3-Hydroxypropionic acid (3-HP), with the formula HOCH₂CH₂COOH, features both a primary hydroxyl group and a group, conferring bifunctional reactivity that allows for reactions such as esterification of the carboxyl group with s or dehydration involving the hydroxyl and carboxyl moieties. This bifunctional nature distinguishes 3-HP from simple monofunctional acids, enabling it to participate in reactions typical of both alcohol and functionalities. The acidity of 3-HP arises from its group, with a (pKa) of 4.51 at 25 °C, indicating moderate acidity comparable to other short-chain s. This property facilitates the formation of salts, such as sodium 3-hydroxypropionate, which exhibits a of 131–135 °C and is utilized in various chemical processes due to its ionic character. In terms of reactivity, 3-HP can undergo lactonization under acidic conditions to yield , a strained four-membered ring , through intramolecular of the hydroxyl and carboxyl groups. The hydroxyl group is susceptible to oxidation, potentially forming 3-oxopropionic acid under appropriate oxidizing conditions, while reduction pathways, such as , can convert 3-HP to by reducing the carboxyl group. Regarding stability, 3-HP thermally decomposes above 200 °C via dehydration to produce and water, a process that can be catalyzed to enhance selectivity. It is sensitive to strong bases, which may promote to form poly(3-hydroxypropionate) through , but remains stable in neutral aqueous solutions at without significant degradation. Spectroscopic characterization confirms the functional groups: infrared (IR) shows characteristic absorption bands at approximately 1710 cm⁻¹ for the C=O stretch of the and 3400 cm⁻¹ for the broad O-H stretch. In ¹H (NMR) (in D₂O), the methylene protons adjacent to the carboxyl group appear around 2.6 ppm (triplet), while those next to the hydroxyl group resonate at about 3.8 ppm (triplet), spanning the 2.5–4.0 ppm range typical for such protons in β-hydroxy acids.

Natural occurrence and biosynthesis

Biological sources

3-Hydroxypropionic acid (3-HP) serves as a metabolic intermediate in various bacterial species, particularly in autotrophic CO₂ fixation pathways. It is notably present in the phototrophic bacterium Chloroflexus aurantiacus, where it functions within the , and in the thermoacidophilic archaeon Metallosphaera sedula, which utilizes the 3-hydroxypropionate/4-hydroxybutyrate cycle for carbon assimilation. In eukaryotic organisms, 3-HP has been detected in endophytic fungi isolated from organs, such as birch twigs and leaves of tropical trees, where it exhibits nematicidal properties. Additionally, it arises in the through the breakdown of branched-chain and , contributing to microbial metabolic processes. It is also produced by common bacteria such as and as a microbial intermediate. Within mammalian systems, 3-HP occurs as a minor derived from propionate , with relevance to disorders of propionyl-CoA carboxylase deficiency. Its presence was first documented in in the during investigations of propionate β-oxidation in liver and urine. Concentrations of 3-HP in natural environments, such as hot springs inhabited by thermophilic bacteria or soil microbial communities, are typically low, reflecting its role as a transient intermediate rather than an accumulated product.

Metabolic pathways

The 3-hydroxypropionate bicycle operates in phototrophic bacteria such as Chloroflexus aurantiacus as a carbon fixation pathway that assimilates two molecules of CO₂ to produce glyoxylate from . The pathway commences with the of to , catalyzed by acetyl-CoA/propionyl-CoA carboxylase. is subsequently reduced to 3-hydroxypropionic acid (3-HP) by the bifunctional malonyl-CoA reductase (MCR), which performs a two-step NADPH-dependent reduction via the intermediate malonate semialdehyde, releasing CO₂ and in the process. The net reaction for the MCR-catalyzed reduction is: \text{Malonyl-CoA} + 2\text{NADPH} + 2\text{H}^{+} \rightarrow \text{3-HP} + \text{CoA} + \text{CO}_{2} + 2\text{NADP}^{+} This step establishes the C3 unit essential for further cycle progression, where 3-HP is activated to 3-hydroxypropionyl-CoA (3-HP-CoA) via CoA transferase (using succinyl-CoA as donor), dehydrated to acryloyl-CoA by 3-hydroxypropionyl-CoA dehydratase, and reduced to propionyl-CoA by acryloyl-CoA reductase using NADPH. A related autotrophic pathway, the 3-hydroxypropionate/4-hydroxybutyrate (3-HP/4-HB) cycle, functions in chemolithoautotrophic and thermoacidophilic including Metallosphaera sedula and Acidianus brierleyi. Here, carboxylation yields , which is reduced to 3-HP through sequential action of malonyl-CoA reductase (producing malonate semialdehyde) and malonate semialdehyde reductase, both NADPH-dependent. The 3-HP is then converted to 3-HP-CoA by 3-hydroxypropionyl-CoA synthetase (using ATP), dehydrated to acryloyl-CoA, and reduced to propionyl-CoA. In anaerobic conditions, this facilitates propionate by channeling the propionyl-CoA intermediate toward propionate production, supporting energy conservation and carbon assimilation.

Synthesis

Chemical synthesis

One established chemical synthesis route for 3-hydroxypropionic acid (3-HP) involves the hydrolysis of , which is first prepared from and in the presence of a Friedel–Crafts catalyst such as zinc chloride-modified aluminum chloride. The [2+2] between and yields as a strained four-membered ring , which readily undergoes ring-opening in aqueous media, often under acidic or basic conditions, to produce 3-HP. This method, while effective for laboratory-scale preparation, requires careful handling due to the reactivity and potential toxicity of . Another route proceeds from via with in the presence of and a catalyst, such as cobalt-based systems, under high pressure (typically 100–200 atm) and elevated temperatures (150–200°C). The reaction forms as an intermediate, which is subsequently hydrolyzed to 3-HP, though direct incorporation of can yield 3-HP or its esters alongside side products like . The overall process can be represented as: \text{Ethylene oxide} + \text{CO} + \text{H}_2\text{O} \xrightarrow{\text{catalyst}} \text{HO-CH}_2\text{-CH}_2\text{-COOH} This pathway is limited by side reactions and the need for high-energy conditions. The Reformatsky reaction provides a classical laboratory method, involving the zinc-mediated addition of ethyl bromoacetate to formaldehyde to form ethyl 3-hydroxypropionate, followed by saponification and acidification to yield 3-HP. This organozinc addition proceeds under mild conditions in solvents like benzene or ether, offering good selectivity for the β-hydroxy ester intermediate, though purification steps are required to isolate the final acid. Additional routes include the catalytic hydration of using acid catalysts such as ion-exchange resins (e.g., resins) at moderate temperatures (60–100°C), achieving equilibrium conversions around 50–60% due to the reversibility of the addition. Alternatively, of with (CO/H₂) over or catalysts produces 3-hydroxypropanal, which is then oxidized (e.g., with air or ) to 3-HP. These methods, while versatile, suffer from reliance on non-renewable petrochemical feedstocks like propylene-derived or , alongside high energy demands for pressure and temperature control.

Biotechnological production

Biotechnological production of 3-hydroxypropionic acid (3-HP) relies on engineered microbial fermentation processes that introduce heterologous pathways into suitable host organisms to convert renewable feedstocks into the target compound. Primary hosts include Escherichia coli, Saccharomyces cerevisiae, and Lactobacillus strains such as L. reuteri, which have been modified to express non-native enzymes for efficient 3-HP synthesis. These organisms are selected for their robust growth, genetic tractability, and ability to tolerate acidic conditions, enabling scalable fermentation. Additional hosts like Halomonas bluephagenesis have achieved the highest reported titer of 154 g/L from 1,3-propanediol via fed-batch fermentation. Key strategies involve the pathway, where glucose is metabolized via to pyruvate and subsequently to , which is carboxylated to by overexpressed (). is then reduced to 3-HP through a multi-step enzymatic process catalyzed by (), often a bifunctional requiring NADPH. This pathway is implemented by of genes like acc and mcr from sources such as Chloroflexus aurantiacus, with additional optimizations like cofactor balancing to enhance flux. The simplified reaction sequence is: \text{Glucose} \rightarrow 2 \text{ Acetyl-CoA} \rightarrow \text{Malonyl-CoA} \rightarrow \text{3-HP (via multi-step enzymatic reduction)} Fed-batch fermentation processes have achieved titers of 50–100 g/L in engineered E. coli and related hosts, with yields approaching 0.5 g/g glucose, as demonstrated in optimized E. coli strains reaching 76.2 g/L from glycerol at 0.45 g/g. Challenges such as 3-HP toxicity to cells, which inhibits growth at concentrations above 50 g/L, are mitigated through in situ extraction techniques like reactive extraction with amines or membrane contactors to continuously remove the product and maintain productivity. These methods prevent accumulation and allow prolonged fermentation runs, improving overall process economics. Renewable feedstocks like sugars derived from corn starch (glucose) or lignocellulosic biomass (xylose and glucose mixtures) serve as carbon sources, supporting sustainable production. To address redox imbalances in the pathway, particularly NADPH demand, co-production with 1,3-propanediol (1,3-PDO) is employed in glycerol-based fermentations, as seen in L. reuteri and E. coli hybrids yielding 125.93 g/L 3-HP alongside 88.46 g/L 1,3-PDO at 0.95 g/g total yield. This strategy recycles cofactors and valorizes by-products from biodiesel industries. Recent advances include CRISPR-edited pathways in such as Synechocystis sp. PCC 6803 for direct CO₂ utilization, enabling photosynthetic 3-HP production at titers up to 0.83 g/L via the route under autotrophic conditions, as reported in studies up to 2023. These developments leverage for carbon fixation, reducing reliance on external sugars and offering a pathway toward carbon-neutral .

Applications

Platform chemical derivatives

3-Hydroxypropionic acid (3-HP) serves as a versatile platform chemical, enabling the synthesis of various industrial intermediates through targeted chemical transformations such as , oxidation, esterification, and . These derivatives leverage 3-HP's hydroxyl and carboxyl functionalities to produce high-value compounds used in polymers, pharmaceuticals, and solvents, contributing to sustainable chemical from renewable feedstocks. Dehydration of 3-HP to is a key process, typically conducted in the gas or liquid phase using acidic heterogeneous catalysts like , which provides weak acid sites for selective elimination of . The reaction occurs at temperatures of 150–300 °C, achieving complete conversion of 3-HP with selectivity and yields exceeding 99%. In February 2025, announced acceleration of commercial production of 100% plant-based derived from 3-HP produced by microbial of plant-based raw materials. , the primary product, is widely applied in the production of superabsorbent polymers for products and as a in paints and coatings, with global demand surpassing 6 million metric tons annually. Oxidation of 3-HP yields through the conversion of the primary hydroxyl group to a , performed via catalytic methods in aqueous media using catalysts such as on . Optimal conditions include temperatures of 20–60 °C, 7.5–9 maintained by hydroxides, and oxygen as the oxidant, resulting in high yields of or its salts. finds applications in the synthesis of pharmaceuticals, such as barbiturates, and in dyes and agrochemicals. Esterification of 3-HP produces 3-hydroxypropyl esters by with alcohols under acidic , yielding compounds suitable for use as solvents in coatings or as plasticizers in flexible materials. These esters maintain the hydroxyl group for further functionalization, enhancing their utility in industrial formulations. of 3-HP to involves reduction of the group in the liquid phase using ruthenium-based catalysts, often supported on or silica, under pressure to achieve high selectivity. Yields approach 98% under optimized conditions, with the product serving as a monomer for (PTT) fibers, such as DuPont's brand used in textiles and carpets. As of , modeled minimum selling prices for bio-based 3-HP from industrial-scale are approximately $2–5 per kg, positioning it as a cost-competitive precursor for bio-derived and enabling economic viability in large-scale .

Polymer production

3-Hydroxypropionic acid (3-HP) serves as a key for producing poly(3-hydroxypropionate) (P3HP), a biodegradable belonging to the polyhydroxyalkanoate (PHA) family. P3HP is synthesized through bacterial where 3-HP is converted to 3-HP-CoA and polymerized intracellularly by PHA synthase enzymes, accumulating as granules within engineered microorganisms such as or Halomonas bluephagenesis. This biological route mirrors the biosynthesis of other PHAs, utilizing substrates like or to achieve high content, up to 92 wt% of cell dry weight in optimized strains. Industrial production of P3HP also includes chemical methods, such as of (the cyclic form of 3-HP) or direct polycondensation of 3-HP derived from hydration. These approaches enable scalable synthesis, with recent fed-batch s yielding up to 80 g/L of P3HP homopolymer in recombinant E. coli within 45 hours. Direct to polymer granules remains predominant for , while chemical routes address limitations in biological yields. P3HP exhibits a melting point of approximately 70–80 °C and a glass transition temperature of −20 °C, rendering it highly flexible with high tensile strength and elongation at break, alongside excellent biodegradability and biocompatibility. These properties suit applications in packaging films, injection-molded products, and thermoforming, where its ductility outperforms more brittle PHAs like poly(3-hydroxybutyrate). In biomedical devices, P3HP's non-toxicity supports uses in tissue engineering scaffolds. Compared to polylactic acid (PLA), P3HP demonstrates greater hydrophilicity due to its odd-numbered carbon chain and pendant hydroxyl groups, enhancing water permeability but potentially requiring blending for moisture-sensitive uses. Copolymers of 3-HP with 4-hydroxybutyric acid (P(3HP-co-4HB)) expand material versatility, forming elastomers with tunable compositions from 12–82 mol% 4HB via recombinant E. coli fed mixtures of and . These copolymers display melting points from 35–78 °C and reduced tensile strength (0.64–33.8 ) with increasing 4HB content, achieving full at higher 4HB fractions. Their and elasticity make them ideal for medical implants, such as resorbable sutures and vascular grafts, leveraging the elastomeric nature absent in P3HP homopolymer. Early P3HP productions faced challenges with low molecular weights (around 10^5 ), limiting mechanical integrity due to inefficient . Advances by 2025, including pathway and cofactor optimization in halophilic , have overcome this, achieving polymer titers exceeding 50 g/L and higher molecular weights for robust thermoplastics.

Research and development

Genetic engineering systems

Genetically encoded inducible systems for 3-hydroxypropionic acid (3-HP) production were characterized in the , leveraging 3-HP as a for factors to enable precise, dose-dependent in microbial hosts such as . These systems, derived from bacteria like Pseudomonas denitrificans and , utilize LysR-type transcriptional regulators (LTTRs) that respond specifically to 3-HP concentrations, facilitating orthogonal control in engineered strains without interfering with native metabolism. The mechanism involves 3-HP binding to repressor proteins, such as C3-LysR or HpdR from propionate and 3-HP degradation pathways, which alters their conformation and derepresses target promoters like P_hpdH. This binding enhances recruitment, leading to upregulation of downstream genes with fold inductions ranging from 23-fold in E. coli at 10 mM 3-HP to over 140-fold in native hosts at 25 mM. Applications include dynamic metabolic control, where 3-HP levels trigger expression of pathway enzymes only when thresholds are approached, thereby balancing production and cell viability during . In , these 3-HP sensors have been integrated into genetic circuits for advanced pathway regulation, including coupling production to cell growth via antibiotic resistance markers for adaptive laboratory evolution. For instance, biosensor-driven selection in E. coli rewired central carbon flux toward 3-HP biosynthesis, with CRISPR-Cas9 used to introduce targeted mutations in genes like cyaA and crp for on/off pathway switches. This approach enabled combinatorial engineering, achieving yields up to 0.91 g/g (91% of theoretical maximum) in fed-batch . Such systems offer advantages in tight , with demonstrated and improvements of 37–48% over parental strains by minimizing acetate overflow and . Early demonstrations combined 3-HP sensors with pathways in E. coli, converting 3-HP to via enzymes like propionyl-CoA synthetase and hydrolase, enabling real-time monitoring of intracellular levels up to 4.2 g/L. However, limitations include with structurally similar acids like propionate, butyrate, and 3-hydroxybutyrate, which can reduce specificity in complex fermentations.

Market and industrial advances

The global 3-hydroxypropionic acid (3-HP) market was estimated at USD 713.8 million in 2023 and is projected to reach USD 1.4 billion by 2030, expanding at a (CAGR) of 9.5% from 2024 to 2030, fueled by rising demand for sustainable bio-based chemicals in polymers and platform compounds. Major industry players, including , , , and , have invested heavily in technologies and facilities for bio-3-HP production; for instance, and collaborated on microbial processes since 2008, while initiated commercial-scale production of bio-acrylic acid derived from 3-HP in early 2025 using plant-based feedstocks. Recent industrial advances encompass integrating 3-HP with biorefineries to utilize waste feedstocks such as , enhancing resource efficiency and reducing costs. Engineered strains have achieved titers up to 71.9 g/L through optimized metabolic pathways (as reported in 2015, with ongoing research). Recent advances include titers up to 154 g/L in fed-batch processes and 100 g/L in engineered yeast (Yarrowia lipolytica) as of 2025, paving the way for higher-yield commercial processes. Bio-based 3-HP production offers benefits, including a reduced compared to routes for derivatives like , with lifecycle analyses showing potential emissions reductions of 10-50% through renewable feedstocks. Biobased polymers have gained regulatory approvals in the and under frameworks like the USDA BioPreferred program and Action Plan, supporting their use in and textiles. Key challenges in include scaling downstream purification to achieve high purity at low cost and ensuring economic competitiveness against established propylene-based chemical routes. projections indicate potential growth to approximately $1.4 billion by 2030, contingent on expanded applications in and broader adoption of bio-based platforms.